Search - tctmd.com

Displaying 141 - 160 of 193

Sort: Relevancy | Date

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

Atrial Fibrillation Risk Increased in People With Asthma

Michael O'Riordan

July 13, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

News Daily News

FDA Warns Certain Zoll LifeVests Might Fail to Deliver Shocks

Michael O'Riordan

January 17, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

Advertisement

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Atrial Fibrillation Risk Increased in People With Asthma

New Review Probes Possibility of CVD Prevention Without Aspirin

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

FDA Warns Certain Zoll LifeVests Might Fail to Deliver Shocks

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Live From Denver: TCT 2017, Day Four

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

NOAC Bleeding Risk Rises With Several Drug Combinations

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Betrixaban Approved for Prevention of VTE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content